Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boundless Mind was a private U.S. behavior-change AI company that applied neuroscience and machine learning to personalize digital interventions intended to shape healthy habits and improve engagement. Formerly known as Dopamine Labs, the company developed analytics and reinforcement tools that predicted when and how to deliver prompts or rewards to influence user behavior. Its technology was used in health, productivity, and wellness use cases, including support for exercise, diet, to-do completion, and medication adherence. In October 2019, Boundless Mind was acquired by Thrive Global, which integrated the team and technology into Thrive’s broader health and productivity behavior-change platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boundless Mind.